Trending
No Evidence Of Increased Blood Clot Risk From COVID-19 Vaccine: AstraZeneca's Review Report
Amid blood clot concerns, AstraZeneca Plc, on Sunday, announced that a review of safety data of people who received its COVID-19 vaccine had shown no signs of an elevated risk of blood clots. The review analysed the safety data of over 17 million people, who received AstraZeneca's vaccine in the...